Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus?
| Image |  |
|---|---|
| Description | scientific article published in July 2011 |
| Author/s |
author: Dafna D. Gladman |
| Publication date | July 1, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |